Acquired platelet antagonism: off-target antiplatelet effects of malignancy treatment with tyrosine kinase inhibitors

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)1686-1699
Number of pages14
JournalJournal of Thrombosis and Haemostasis
Volume16
Issue number9
DOIs
Publication statusPublished - 1 Sep 2018

Keywords

  • cancer
  • platelets
  • signaling
  • therapy
  • tyrosine kinase inhibitor
  • CHRONIC MYELOID-LEUKEMIA
  • CELL LUNG-CANCER
  • CHRONIC LYMPHOCYTIC-LEUKEMIA
  • ENDOTHELIAL GROWTH-FACTOR
  • FACTOR RECEPTOR INHIBITOR
  • BCR-ABL INHIBITOR
  • PHASE-2 TRIAL
  • DOUBLE-BLIND
  • OPEN-LABEL
  • ANGIOGENESIS INHIBITORS

Cite this